Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

March 06, 2015 8:53 PM ET


Company Overview of St. Charles Pharmaceuticals, Inc.

Executive Profile

Kenneth W. Narducy Ph.D., MBA

Co-Founder, President and Director, St. Charles Pharmaceuticals, Inc.
AgeTotal Calculated CompensationThis person is connected to 2 Board Members in 2 different organizations across 3 different industries.

See Board Relationships


Dr. Kenneth W. Narducy,Ken, PhD, MBA co-founded St. Charles Pharmaceuticals, Inc. in 1997 and serves as its President. Dr. Narducy has many years of drug development experience. Dr. Narducy served as the Vice President and General Manager of Centaur Pharmaceuticals Inc.; Executive Vice President and President at Oculex Pharmaceuticals; Vice President of Research and Development at CooperVision Ophthalmic Products; Director of Research and Development at Wesley-Jessen; ...

Corporate Headquarters

2020 Gravier Street
New Orleans, Louisiana 70112

United States

Phone: 504-568-8542
Fax: --

Board Members Memberships

Chairman of the Board
Co-Founder, President and Director


The Ohio State University
The University of Chicago

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup


There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact St. Charles Pharmaceuticals, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at